
Daniel C Zedek MD
Dermatopathology, Anatomic Pathology, Clinical Pathology
Assistant Professor, Dermatology, University of North Carolina at Chapel
Join to View Full Profile
414 Mary Ellen Jones BuildingUNC CB 7287Chapel Hill, NC 27599
Phone+1 919-843-2482
Are you Dr. Zedek?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Daniel Zedek, MD is a board certified pathologist in Chapel Hill, North Carolina. He is currently licensed to practice medicine in North Carolina, South Carolina, and Florida. He is an Assistant Professor at University of North Carolina at Chapel.
Education & Training
- University of North Carolina HospitalsResidency, Pathology-Anatomic and Clinical, 2004 - 2008
- University of South Carolina School of MedicineClass of 2004
Certifications & Licensure
- CA State Medical License 2008 - 2026
- FL State Medical License 2021 - 2026
- VA State Medical License 2016 - 2026
- LA State Medical License 2021 - 2025
- NC State Medical License 2004 - 2025
- NC State Medical License 2006 - 2025
- SC State Medical License 2022 - 2025
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Dermatopathology
- Join now to see all
Publications & Presentations
PubMed
- 25 citationsIdentification of a Robust Methylation Classifier for Cutaneous Melanoma DiagnosisKathleen Conway, Sharon N. Edmiston, Joel S. Parker, Pei Fen Kuan, Yi-Hsuan Tsai
The Journal of Investigative Dermatology. 2019-06-01 - 26 citationsUtility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis.Nancy E. Thomas, Sharon N. Edmiston, Yihsuan S. Tsai, Joel S. Parker, Paul B. Googe
The American Journal of Dermatopathology. 2019-04-01 - 2 citationsGranulation tissue masquerading as basal cell carcinoma after treatment with vismodegib.Jayson Miedema, Michael O. Meyers, Daniel C. Zedek, Michelle C. Roughton, Puneet S. Jolly
JAAD Case Reports. 2018-01-01